Table 2.
GBS colonisation in newborns of women with GBS rectovaginal colonisation | GBS colonisation in newborns of women without rectovaginal GBS colonisation |
|||
---|---|---|---|---|
n/N | % (95% CI) | n/N | % (95% CI) | |
Bangladesh | 77/138 | 55·8% (47·5–63·8) | 32/650 | 4·9% (95% CI 3·5–6·9) |
Ethiopia | 67/87 | 77% (67·1–84·6) | 25/667 | 3·7% (95 CI 2·6–5·5) |
India | 134/174 | 77% (70·2–82·6) | 30/67 | 4·4% (95 CI 3·1–6·3) |
Kenya | 128/169 | 75·7% (68·8–81·6) | 26/630 | 4·1% (95 CI 2·8–6) |
Mali | 247/314 | 78·7% (73·8–82·8) | 46/450 | 10·2% (95 CI 7·8–13·4) |
Mozambique | 168/212 | 79·2% (73·3–84·2) | 20/573 | 3·5% (95 CI 2·3–5·3) |
Nigeria | 125/201 | 62·2% (55·3–68·6) | 31/673 | 4·6% (95 CI 3·3–6·5) |
South Africa | 186/271 | 68·6% (62·9–73·9) | 47/610 | 7·7% (95 CI 5·8–10·1) |
Overall | 1132/1566 | 72·3% (70·0–74·4) | 257/4929 | 5·2% (95 CI 4·6–5·9) |
GBS=group B Streptococcus.